41 high-performance-quantum-computing-"https:"-"https:" Fellowship positions at Nature Careers
Sort by
Refine Your Search
-
well as the R&D and application of high technology for marine environmental protection and resources exploration. It is a large-scale public welfare marine research institute with outstanding scientific and
-
The Neuro-Oncology Branch (NOB) at the National Cancer Institute’s Center for Cancer Research (CCR) is a specialized program dedicated to advancing the study and treatment of brain and central
-
approach that supports every researcher. This gives us the freedom to take risks and carry out high-quality, pioneering research. Creating a space for discovery without boundaries helps us to turn our
-
of T-cell-centered chemical immunology and has received major funding from the National Natural Science Foundation of China (including the Distinguished Young Scholars program). Recent work from the lab
-
advancing understanding and treatment of pediatric cancer. Dr. Brian Crompton’s lab is an interdisciplinary team with both computational and wet bench scientists that utilize omics (e.g. genomic, epigenomic
-
apply cutting-edge biomedical technology to empower cancer research. Successful candidates will join our team to contribute to the following project: a) Assessing ultra-high dose rate radiation therapy
-
, providing specialist support for external engagement and development - Our Exeter Academic initiative supports high-performing academics to achieve their potential and develop their career - A multitude of
-
approach is transdisciplinary, transformative, and co-creative. The RIFS awards the Klaus Töpfer Sustainability Fellowship as part of its Fellow Programme. Prof. Dr Klaus Töpfer was the Founding Director of
-
on the production and in vitro characterization of several enzymes in parallel (proteases and hydrolases). This research programme is part of an international effort to answer the call for the development of new
-
, preventing cancer at the community level, identifying and evaluating cancer risk in high-risk populations, and measuring the quality and outcomes of cancer therapy. We invite applications for a fellowship